These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15053988)

  • 1. Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose.
    Camacho RC; Lacy DB; James FD; Coker RH; Wasserman DH
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E269-74. PubMed ID: 15053988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
    Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior exercise and the response to insulin-induced hypoglycemia in the dog.
    Koyama Y; Galassetti P; Coker RH; Pencek RR; Lacy DB; Davis SN; Wasserman DH
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1128-38. PubMed ID: 11934679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
    Liljenquist JE; Mueller GL; Cherrington AD; Keller U; Chiasson J-L ; Perry JM; Lacy WW; Rabinowitz D
    J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
    Rivera N; Everett-Grueter CA; Edgerton DS; Rodewald T; Neal DW; Nishimura E; Larsen MO; Jacobsen LO; Kristensen K; Brand CL; Cherrington AD
    J Pharmacol Exp Ther; 2007 May; 321(2):743-52. PubMed ID: 17308040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
    Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
    Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
    Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
    Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior exercise enhances passive absorption of intraduodenal glucose.
    Pencek RR; Koyama Y; Lacy DB; James FD; Fueger PT; Jabbour K; Williams PE; Wasserman DH
    J Appl Physiol (1985); 2003 Sep; 95(3):1132-8. PubMed ID: 12740315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
    Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
    Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin infusion inhibits glucose production in burn patients.
    Wolfe RR; Burke JF
    Circ Shock; 1982; 9(5):521-7. PubMed ID: 6129073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion.
    Moore MC; Cardin S; Edgerton DS; Farmer B; Neal DW; Lautz M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E226-33. PubMed ID: 14519598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the vagus nerves in the regulation of basal hepatic glucose production in conscious dogs.
    Cardin S; Walmsley K; Neal DW; Williams PE; Cherrington AD
    Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E958-64. PubMed ID: 12376322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E380-4. PubMed ID: 18056788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin action during late pregnancy in the conscious dog.
    Connolly CC; Aglione LN; Smith MS; Lacy DB; Moore MC
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E909-15. PubMed ID: 14749203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
    An Z; DiCostanzo CA; Moore MC; Edgerton DS; Dardevet DP; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E300-6. PubMed ID: 18029444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.